The phospholipase D superfamily as therapeutic targets

被引:150
作者
Frohman, Michael A. [1 ,2 ]
机构
[1] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA
[2] SUNY Stony Brook, Ctr Mol Med 438, Ctr Dev Genet, Stony Brook, NY 11794 USA
关键词
PLD1; PLD2; small-molecule inhibitors; cancer; thrombosis; autoimmune disease; INDUCED SUPEROXIDE GENERATION; ADRENAL GLOMERULOSA CELLS; PHOSPHATIDIC-ACID; MOLECULAR-MECHANISMS; LYMPHOCYTE ADHESION; THROMBUS FORMATION; MOUSE NEUTROPHILS; RUFFLE FORMATION; PLASMA-MEMBRANE; INFLUENZA-VIRUS;
D O I
10.1016/j.tips.2015.01.001
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
The phospholipase D (PLD) lipid-signaling enzyme superfamily has long been studied for its roles in cell communication and a wide range of cell biological processes. With the advent of loss-of-function genetic mouse models that have revealed that PLD1 and PLD2 ablation is overtly tolerable, small-molecule PLD1/2 inhibitors that do not cause unacceptable clinical toxicity, a PLD2 polymorphism that has been linked to altered physiology, and growing delineation of processes that are subtly altered in mice lacking PLD1/2 activity, the stage is being set for assessment of PLD1/2 inhibition for therapeutic purposes. Based on findings to date, PLD1/2 inhibition may be of more utility in acute rather than chronic settings, although this generalization will depend on the specific risks and benefits in each disease setting.
引用
收藏
页码:137 / 144
页数:8
相关论文
共 65 条
[1]
Deficiencies of the Lipid-Signaling Enzymes Phospholipase D1 and D2 Alter Cytoskeletal Organization, Macrophage Phagocytosis, and Cytokine-Stimulated Neutrophil Recruitment [J].
Ali, Wahida H. ;
Chen, Qin ;
Delgiorno, Kathleen E. ;
Su, Wenjuan ;
Hall, Jason C. ;
Hongu, Tsunaki ;
Tian, Huasong ;
Kanaho, Yasunori ;
Di Paolo, Gilbert ;
Crawford, Howard C. ;
Frohman, Michael A. .
PLOS ONE, 2013, 8 (01)
[2]
Ammar Mohamed Raafet, 2013, Front Endocrinol (Lausanne), V4, P125, DOI 10.3389/fendo.2013.00125
[3]
A genome-wide scan for common alleles affecting risk for autism [J].
Anney, Richard ;
Klei, Lambertus ;
Pinto, Dalila ;
Regan, Regina ;
Conroy, Judith ;
Magalhaes, Tiago R. ;
Correia, Catarina ;
Abrahams, Brett S. ;
Sykes, Nuala ;
Pagnamenta, Alistair T. ;
Almeida, Joana ;
Bacchelli, Elena ;
Bailey, Anthony J. ;
Baird, Gillian ;
Battaglia, Agatino ;
Berney, Tom ;
Bolshakova, Nadia ;
Boelte, Sven ;
Bolton, Patrick F. ;
Bourgeron, Thomas ;
Brennan, Sean ;
Brian, Jessica ;
Carson, Andrew R. ;
Casallo, Guillermo ;
Casey, Jillian ;
Chu, Su H. ;
Cochrane, Lynne ;
Corsello, Christina ;
Crawford, Emily L. ;
Crossett, Andrew ;
Dawson, Geraldine ;
de Jonge, Maretha ;
Delorme, Richard ;
Drmic, Irene ;
Duketis, Eftichia ;
Duque, Frederico ;
Estes, Annette ;
Farrar, Penny ;
Fernandez, Bridget A. ;
Folstein, Susan E. ;
Fombonne, Eric ;
Freitag, Christine M. ;
Gilbert, John ;
Gillberg, Christopher ;
Glessner, Joseph T. ;
Goldberg, Jeremy ;
Green, Jonathan ;
Guter, Stephen J. ;
Hakonarson, Hakon ;
Heron, Elizabeth A. .
HUMAN MOLECULAR GENETICS, 2010, 19 (20) :4072-4082
[4]
Mechanisms of lysophosphatidic acid production [J].
Aoki, J .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2004, 15 (05) :477-489
[5]
Phosphatidic Acid ( PA)-preferring Phospholipase A1 Regulates Mitochondrial Dynamics [J].
Baba, Takashi ;
Kashiwagi, Yuriko ;
Arimitsu, Nagisa ;
Kogure, Takeshi ;
Edo, Ayumi ;
Maruyama, Tomohiro ;
Nakao, Kazuki ;
Nakanishi, Hiroki ;
Kinoshita, Makoto ;
Frohman, Michael A. ;
Yamamoto, Akitsugu ;
Tani, Katsuko .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (16) :11497-11511
[6]
Phospholipase D Signaling Pathways and Phosphatidic Acid as Therapeutic Targets in Cancer [J].
Bruntz, Ronald C. ;
Lindsley, Craig W. ;
Brown, H. Alex .
PHARMACOLOGICAL REVIEWS, 2014, 66 (04) :1033-1079
[7]
Phospholipase D2 Mediates Survival Signaling through Direct Regulation of Akt in Glioblastoma Cells [J].
Bruntz, Ronald C. ;
Taylor, Harry E. ;
Lindsley, Craig W. ;
Brown, H. Alex .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (02) :600-616
[8]
Impaired brain development and reduced cognitive function in phospholipase D-deficient mice [J].
Burkhardt, Ute ;
Stegner, David ;
Hattingen, Elke ;
Beyer, Sandra ;
Nieswandt, Bernhard ;
Klein, Jochen .
NEUROSCIENCE LETTERS, 2014, 572 :48-52
[9]
Presenilin-1 uses phospholipase D1 as a negative regulator of β-amyloid formation [J].
Cai, DM ;
Netzer, WJ ;
Zhong, MH ;
Lin, YX ;
Du, GW ;
Frohman, M ;
Foster, DA ;
Sisodia, SS ;
Xu, HX ;
Gorelick, FS ;
Greengard, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (06) :1941-1946
[10]
Key Roles for the Lipid Signaling Enzyme Phospholipase D1 in the Tumor Microenvironment During Tumor Angiogenesis and Metastasis [J].
Chen, Qin ;
Hongu, Tsunaki ;
Sato, Takanobu ;
Zhang, Yi ;
Ali, Wahida ;
Cavallo, Julie-Ann ;
van der Velden, Adrianus ;
Tian, Huasong ;
Di Paolo, Gilbert ;
Nieswandt, Bernhard ;
Kanaho, Yasunori ;
Frohman, Michael A. .
SCIENCE SIGNALING, 2012, 5 (249)